Vitiligo Vulgaris clinical trials

Explore recruiting vitiligo vulgaris clinical trials.

Recruiting vitiligo vulgaris studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Vitiligo Vulgaris trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, and Tolerability of Upadacitinib in Adult and Adolescent Subjects with Non-Segmental Vitiligo Who Are Eligible for Systemic Therapy

Germany, Spain, Bulgaria, Poland, France, Italy +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Vitiligo Vulgaris trials by city

Vitiligo Vulgaris in Toronto Vitiligo Vulgaris in Vancouver Vitiligo Vulgaris in Montreal Vitiligo Vulgaris in Calgary Vitiligo Vulgaris in Edmonton Vitiligo Vulgaris in Ottawa Vitiligo Vulgaris in Winnipeg Vitiligo Vulgaris in Quebec City Vitiligo Vulgaris in Hamilton Vitiligo Vulgaris in Kitchener Vitiligo Vulgaris in London Vitiligo Vulgaris in Halifax Vitiligo Vulgaris in New York Vitiligo Vulgaris in Los Angeles Vitiligo Vulgaris in Chicago Vitiligo Vulgaris in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease